Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Breast Cancer Female × abemaciclib × Clear all

Phase

Status

Withdrawn 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 21 Neoplasm Metastasis 7 Prostatic Neoplasms 5 Brain Neoplasms 3 Ovarian Neoplasms 2 Oligodendroglioma 2 Endometrial Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Venous Thromboembolism 1 Urogenital Neoplasms 1 Urinary Bladder Neoplasms 1 Small Cell Lung Carcinoma 1 Sarcoma, Ewing 1 Sarcoma 1 Recurrence 1 Rectal Neoplasms 1 Pancreatic Neoplasms 1 Neoplasms by Site 1 Neoplasms 1 Meningioma 1 Malignant Neoplasms of Female Genital Organs 1 Lung Neoplasms 1 Liposarcoma 1 Glioma 1 Glioblastoma 1 Gastro-enteropancreatic neuroendocrine tumor 1 Ependymoma 1 Colorectal Neoplasms 1 Colonic Neoplasms 1 Cardiovascular Diseases 1

Interventions

Tamoxifen 2 pyrotinib 1 exemestane 1 abemaciclib 1 Surgical Procedures, Operative 1 Radiotherapy 1 Radiation Dose Hypofractionation 1 Pentoxifylline 1 Mammaplasty 1 Letrozole 1 Drug Therapy 1 Aromatase Inhibitors 1 Anastrozole 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04584853 2026-01-14

POETIC-A

Institute of Cancer Research, United Kingdom

Phase 3 Active not recruiting

Breast Cancer Female

Data powered by HemOnc (CC BY 4.0) Colophon ⚡